Review



cd44  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    Elabscience Biotechnology cd44
    Cd44, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 11 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/APC+Anti-Human%2FMouse+CD44+Antibody/pm40445451-51-4-11
    Average 93 stars, based on 11 article reviews
    cd44 - by Bioz Stars, 2026-10
    93/100 stars

    Images

    Related Articles

    Staining:

    Article Title: A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy
    Article Snippet: The cells were then blocked with 0.1% BSA (36101ES, Yeasen Bio.) in PBS followed by a 1-hour incubation with specific antibodies at room temperature. .. For the characterization of T cells and DCs in tumors and spleens, staining was performed using anti-mouse CD3-Pcy5.5 (F1013J, Elabscience), anti-mouse CD4-FITC (F1097C, Elabscience), anti-mouse CD8a-PE (F1104D, Elabscience), anti-mouse CD11b-FITC (F1081C, Elabscience), anti-mouse Gr-1-PE (F1120D, Elabscience), anti-mouse IFN-γ-APC (F1101E, Elabscience), anti-mouse Foxp3-PE (F1238D, Elabscience), anti-mouse CD62L-Pcy5.5 (F1011J, Elabscience) and anti-mouse CD44-APC (F1100E, Elabscience). .. Data acquisition was performed using CytExpert software, and analysis was conducted using FlowJo software.

    Article Title: A factorial design-optimized microfluidic LNP vaccine elicits potent magnesium-adjuvating cancer immunotherapy
    Article Snippet: Briefly, samples were dissociated into single-cell suspensions and red blood cells were removed using red blood cell lysis buffer (Solabio, China). .. The samples were then blocked in PBS containing 0.1 % BSA (36101 ES, Yeasen Bio.) and incubated with the relevant antibodies at room temperature for 1 h. To characterize immune cell populations, the following antibodies were used for staining: CD3-Pcy5.5 (F1013J, Elabscience), anti-mouse CD4-FITC (F1097C, Elabscience), anti-mouse CD8a-PE (F1104D, Elabscience), anti-mouse CD11b-FITC (F1081C, Elabscience), anti-mouse Gr-1-PE (F1120D, Elabscience), anti-mouse IFN-γ-APC (F1101E, Elabscience), anti-mouse Foxp3-PE (F1238D, Elabscience), anti-mouse CD62L-Pcy5.5 (F1011J, Elabscience), and anti-mouse CD44-APC (F1100E, Elabscience) (All antibody information was listed in ). ..

    Article Title: A lyophilizable LNP vaccine enables STING-reinforced postoperational adjuvant immunotherapy.
    Article Snippet: The cells were then blocked with 0.1% BSA (36101ES, Yeasen Bio.) in PBS followed by a 1-hour incubation with specific antibodies at room temperature. .. For the characterization of T cells and DCs in tumors and spleens, staining was performed using anti-mouse CD3-Pcy5.5 (F1013J, Elabscience), anti-mouse CD4-FITC (F1097C, Elabscience), anti-mouse CD8a-PE (F1104D, Elabscience), anti-mouse CD11b-FITC (F1081C, Elabscience), anti-mouse Gr-1-PE (F1120D, Elabscience), anti-mouse IFN-γ-APC (F1101E, Elabscience), anti-mouse Foxp3-PE (F1238D, Elabscience), anti-mouse CD62L-Pcy5.5 (F1011J, Elabscience) and anti-mouse CD44-APC (F1100E, Elabscience). .. Data acquisition was performed using CytExpert software, and analysis was conducted using FlowJo software.

    Incubation:

    Article Title: A factorial design-optimized microfluidic LNP vaccine elicits potent magnesium-adjuvating cancer immunotherapy
    Article Snippet: Briefly, samples were dissociated into single-cell suspensions and red blood cells were removed using red blood cell lysis buffer (Solabio, China). .. The samples were then blocked in PBS containing 0.1 % BSA (36101 ES, Yeasen Bio.) and incubated with the relevant antibodies at room temperature for 1 h. To characterize immune cell populations, the following antibodies were used for staining: CD3-Pcy5.5 (F1013J, Elabscience), anti-mouse CD4-FITC (F1097C, Elabscience), anti-mouse CD8a-PE (F1104D, Elabscience), anti-mouse CD11b-FITC (F1081C, Elabscience), anti-mouse Gr-1-PE (F1120D, Elabscience), anti-mouse IFN-γ-APC (F1101E, Elabscience), anti-mouse Foxp3-PE (F1238D, Elabscience), anti-mouse CD62L-Pcy5.5 (F1011J, Elabscience), and anti-mouse CD44-APC (F1100E, Elabscience) (All antibody information was listed in ). ..



    Similar Products

    apc anti mouse cd44  (Miltenyi Biotec)
    94
    Miltenyi Biotec apc anti mouse cd44
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Apc Anti Mouse Cd44, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/CD44+Antibody%2C+anti-mouse%2C+REAfinity/pmc13006431-43-0-6
    Average 94 stars, based on 1 article reviews
    apc anti mouse cd44 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    ‒ anti cd44 apc vio779  (Miltenyi Biotec)
    95
    Miltenyi Biotec ‒ anti cd44 apc vio779
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    ‒ Anti Cd44 Apc Vio779, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/Granzyme+B+Antibody%2C+anti-human%2Fmouse%2Frat%2C+REAfinity/pm42098128-440-54-58
    Average 95 stars, based on 1 article reviews
    ‒ anti cd44 apc vio779 - by Bioz Stars, 2026-10
    95/100 stars
    		  Buy from Supplier
    cd44 apc cy7  (Cytek Biosciences)
    93
    Cytek Biosciences cd44 apc cy7
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Cd44 Apc Cy7, supplied by Cytek Biosciences, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/APC-Cyanine7+Anti-Human%2FMouse+CD44/pm41094529-56-23-24
    Average 93 stars, based on 1 article reviews
    cd44 apc cy7 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    cd44 apc vio 770  (Miltenyi Biotec)
    94
    Miltenyi Biotec cd44 apc vio 770
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Cd44 Apc Vio 770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/CD44+Antibody%2C+anti-mouse/pmc12471919-79-43-49
    Average 94 stars, based on 1 article reviews
    cd44 apc vio 770 - by Bioz Stars, 2026-10
    94/100 stars
    		  Buy from Supplier
    anti mouse cd44 apc  (Proteintech)
    93
    Proteintech anti mouse cd44 apc
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Anti Mouse Cd44 Apc, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/APC+Anti-mouse+CD44/pm40602573-53-12-21
    Average 93 stars, based on 1 article reviews
    anti mouse cd44 apc - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier
    apc-conjugated anti-human/mouse cd44 antibody f1104403  (MultiSciences Biotech Co Ltd)
    90
    MultiSciences Biotech Co Ltd apc-conjugated anti-human/mouse cd44 antibody f1104403
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Apc Conjugated Anti Human/Mouse Cd44 Antibody F1104403, supplied by MultiSciences Biotech Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/antibodies+against+cd29++cd31++cd34++cd44++cd45++cd166/pmc12213820-74-13-18
    Average 90 stars, based on 1 article reviews
    apc-conjugated anti-human/mouse cd44 antibody f1104403 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    syrian hamster anti cd3 rat anti cd8 rat anti cd44 rat anti cd62l live deadtm fixable near ir 780 viability kit mouse anti cd45 2 annexin v apc hamster anti klrg1 rat anti cd127 rat anti lag 3 rat anti pd 1 rat anti tim 3 mouse anti cx3cr1 rat anti cd101 mouse anti ly108 armenian hamster anti cd69 streptavidin v500  (Thermo Fisher)
    99
    Thermo Fisher syrian hamster anti cd3 rat anti cd8 rat anti cd44 rat anti cd62l live deadtm fixable near ir 780 viability kit mouse anti cd45 2 annexin v apc hamster anti klrg1 rat anti cd127 rat anti lag 3 rat anti pd 1 rat anti tim 3 mouse anti cx3cr1 rat anti cd101 mouse anti ly108 armenian hamster anti cd69 streptavidin v500
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Syrian Hamster Anti Cd3 Rat Anti Cd8 Rat Anti Cd44 Rat Anti Cd62l Live Deadtm Fixable Near Ir 780 Viability Kit Mouse Anti Cd45 2 Annexin V Apc Hamster Anti Klrg1 Rat Anti Cd127 Rat Anti Lag 3 Rat Anti Pd 1 Rat Anti Tim 3 Mouse Anti Cx3cr1 Rat Anti Cd101 Mouse Anti Ly108 Armenian Hamster Anti Cd69 Streptavidin V500, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/Streptavidin/pmc12316916-5-0-41
    Average 99 stars, based on 1 article reviews
    syrian hamster anti cd3 rat anti cd8 rat anti cd44 rat anti cd62l live deadtm fixable near ir 780 viability kit mouse anti cd45 2 annexin v apc hamster anti klrg1 rat anti cd127 rat anti lag 3 rat anti pd 1 rat anti tim 3 mouse anti cx3cr1 rat anti cd101 mouse anti ly108 armenian hamster anti cd69 streptavidin v500 - by Bioz Stars, 2026-10
    99/100 stars
    		  Buy from Supplier
    cd44  (Elabscience Biotechnology)
    93
    Elabscience Biotechnology cd44
    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic <t>CD44</t> + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .
    Cd44, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/anti+mouse+cd44+apc/APC+Anti-Human%2FMouse+CD44+Antibody/pm40445451-51-4-11
    Average 93 stars, based on 1 article reviews
    cd44 - by Bioz Stars, 2026-10
    93/100 stars
    		  Buy from Supplier

    Image Search Results


    Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic CD44 + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .

    Journal: Cell Reports Medicine

    Article Title: Valrubicin-loaded immunoliposomes targeting antigens on immunosuppressive cells to circumvent resistance to cancer immunotherapy

    doi: 10.1016/j.xcrm.2026.102632

    Figure Lengend Snippet: Val-ILs and αPD-1 affect the growth and spread of breast tumor cells 10 6 4T1 cells were transplanted through i.d. injection into the mammary gland of female BALB/c mice. When tumors reached 50 mm 3 , mice were i.v. injected with Val-ILs (10 12 NPs) and i.p. injected with αPD-1 (200 μg) on days 6, 9, and 12. Analyses were performed on day 15 (A–E). (A) Tumor growth volumes measured in vivo. (B) Image of tumors isolated ex vivo from the mammary gland of mice (two independent in vivo experiments). Val-ILs-Combo was efficient in reducing the tumor volumes, and the combination of Val-ILs-Combo and αPD-1 was even more efficient. Mice without breast tumors are identified with a black cross. (C) FC on TAM cells in the TME and macrophages in the spleen, to identify M1-like and M2-like phenotypes. (D) Images of mice measured with in vivo imaging system technology showing the detection of bioluminescent 4T1 cells in the mammary gland, following treatment with Val-ILs-Combo and/or αPD-1. (E) FC was used to detect metastatic CD44 + GFP + 4T1 cells spreading to distant organs following treatment. Examples of FC plots and a heatmap displaying the mean percentages. Undetected (ud) indicates the absence of detectable tumor 4T1 cells. (F) On day 30, tumor-free mice were rechallenged with a secondary injection of 10 6 4T1 cells into the contralateral mammary gland. Tumor growth was monitored to evaluate the establishment of a protective anti-tumor memory. The number of mice used per group is indicated on the figure, data are shown as means ± SD, and p values are compared to Val-ILs-IgG + αIgG or between the different groups and are calculated using one-way ANOVA with Tukey’s multiple comparisons test. See also .

    Article Snippet: APC anti-Mouse CD44 (Clone REA664) , Miltenyi Biotec , Cat# 130-119-121; RRID: AB_2751628.

    Techniques: Injection, In Vivo, Isolation, Ex Vivo, In Vivo Imaging